Everything Is Tuberculosis: The History and Persistence of Our Deadliest Infection

by John Green

When markets tell companies it’s more valuable to develop drugs that lengthen eyelashes than to develop drugs that treat malaria or tuberculosis, something is clearly wrong with the incentive structure.